Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic Adds Telehealth Services With Cardiocom Acquisition

This article was originally published in The Gray Sheet

Executive Summary

Medtronic hopes the $200 million purchase of telehealth firm Cardiocom will enhance its ability to respond to increasing demands on hospitals to better manage patient outcomes and costs. It will also greatly expand its customer base.

Advertisement

Related Content

Medtronic Takes Next Step As Heart-Failure Service Provider
Medtronic Takes Next Step As Heart-Failure Service Provider
Boston Scientific Thinks Big In Heart Failure Risk-Share Plan
Medtronic Hints At Greater Diagnostic Focus
Medtronic And Covidien Continue Shopping In Advance Of Pairing
Philips Emphasizes Services With New Division: Q&A With Jeroen Tas
CMS Updates Medicare Readmissions Policy, Other Quality Initiatives
Smart Orthopedic Implants
Mobile Health In Brief
GE-Intel: Corporate Powerhouses Create Global Home Telehealth Firm

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT032331

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel